Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11464 posts found.

C4X Discovery signs licensing deal worth up to $402m with AstraZeneca

November 28, 2022 Sales and Marketing

Pioneering drug discovery company, C4X Discovery Holdings (C4XD) has signed a licensing agreement with AstraZeneca, worth up to $402m. The …
News

Novo Nordisk suffers profit loss over obesity drug as manufacturing problems continue

November 23, 2022 Sales and Marketing

Danish pharma company Novo Nordisk, has reported a 2% loss in their third quarter sales report, compared to the previous …
News

Haemophilia drug costing $3.5m per dose has been approved

November 23, 2022 Sales and Marketing

CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price …
News

Approval of only twice-yearly HIV treatment option

August 22, 2022 Sales and Marketing

The European Commission (EC) has granted a Marketing Authorisation for Sunlenca (lenacapavir) injection and tablets for the treatment of HIV …
News

NICE issues positive appraisal document for combination treatment for advanced kidney cancer

August 22, 2022 Sales and Marketing

NICE has published an appraisal consultation document (ACD) recommending the use of lenvatinib as a therapeutic option for untreated intermediate …
News

EMA accept marketing authorisation application for invasive candidiasis treatment

August 22, 2022 Sales and Marketing

The EMA has accepted the marketing authorisation application (MAA) for rezafungin, for the treatment of invasive candidiasis in adult patients. …
News

New WHO recommendations for Ebola treatments and improved access

August 22, 2022 Sales and Marketing

WHO has published its first guideline for Ebola virus disease therapeutics, calling on the global community to increase access to …
News

Sanofi and NIHR enrol first patient in immunisation study for RSV in infants

August 15, 2022 Sales and Marketing

The European study will evaluate the use of the human recombinant monoclonal antibody nirsevimab   Sanofi and the National Institute …
News

NHS England outlines measures to boost capacity ahead of substantial winter pressures

August 15, 2022 Sales and Marketing

The package of measures includes creating the equivalent of 7,000 additional hospital beds   NHS England has announced a package …
News
blood_brain

Focused ultrasound therapies could be made more affordable by 3D-printed acoustic holograms to help overcome the blood-brain barrier

August 15, 2022 Sales and Marketing

The 3D-printed acoustic hologram is used with focused ultrasound (FUS) to create a more controlled and precise opening in the …
News
brain_fgo

Cognitive rehabilitation therapy may help older adults clear COVID-19-related brain fog

August 15, 2022 Sales and Marketing

Medical centres in the US have started referring older patients with long COVID-19-related symptoms for cognitive rehabilitation in order to …
News

HUTCHMED’s metastatic colorectal cancer treatment meets primary endpoint in Phase III trial

August 8, 2022 Sales and Marketing

HUTCHMED has announced that its global Phase III FRESCO-2 trial, evaluating the investigational use of fruquintinib, reached its primary endpoint …
News

Another “Winter crisis” on horizon for NHS without urgent action

August 8, 2022 Sales and Marketing

The NHS in England could face “very serious challenges coming down the track” without significant action tackling the emergency crisis …
News

SIGA will seek FDA approval of monkeypox treatment once data is available

August 8, 2022 Sales and Marketing

The CEO of SIGA Technologies has announced that they are planning to ask the FDA for approval and authorisation for …
News

Melanoma cells use ‘molecular drills’ to invade new tissues, research finds

August 8, 2022 Sales and Marketing

Scientists have identified a nerve cell gene that enables melanoma cells to branch out and invade new tissues. Research from …
News

Latest content

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023

FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023